<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>18338922</identifier>
<setSpec>1130-1406</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Reviákina, Vera</dc:author>
<dc:author>Papatzikos, Juana</dc:author>
<dc:author>Calvo, Alberto</dc:author>
<dc:author>Selgrad, Sofía</dc:author>
<dc:author>Moreno, Xiomara</dc:author>
<dc:author>Dolande Franco, Maribel E</dc:author>
<dc:author>Macero, Carolina</dc:author>
<dc:author>Panizo, María Mercedes</dc:author>
<dc:author>Vergara, Vivian</dc:author>
<dc:author>Mendoza, María José</dc:author>
<dc:description xml:lang="en">The aim of this study was to investigate the frequency and antifungal susceptibility of Candida clinical isolations coming from patients with candidiasis in six health care centers of Caracas, Venezuela metropolitan area. The laboratory reports were retrospectively revised from January 2003 through August 2005. The isolated yeasts identification was carried out by conventional methods and antifungal susceptibility was evaluated by ATB-fungus (bioMérieux, France) and Etest (AB Biodisk, Solna, Sweden). One thousand nine hundred seventy seven (1.977) yeasts were studied and their susceptibility testing were carried out only in 1,414 of them. C. albicans was the most isolated yeast (46.7%) and none-albicans Candida-species represented more than half of the isolations (53.4%). All the isolated yeasts evaluated presented CMIs&lt;1 microg/ml to anfotericina B and showed variable susceptibility percentages to fluconazole (91.5%), itraconazole (80%) and voriconazole (98.6%).</dc:description>
<dc:type>Comparative Study</dc:type>
<dc:language>es</dc:language>
<dc:date>2008 Mar </dc:date>
<dc:title xml:lang="es">Distribución y sensibilidad a los antifúngicos de aislamientos clínicos de Candida en seis centros de salud del área metropolitana de Caracas, Venezuela (años 2003-2005).</dc:title>
<dc:title xml:lang="en">[Distribution and antifungal susceptibility of Candida clinical isolations coming from six health care centers in the metropolitan area of Caracas, Venezuela (years 2003-2005)].</dc:title>
<dc:publisher>Revista iberoamericana de micologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
